Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Homology Medicines, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$6.02 - $9.64 $227,038 - $363,562	-37,714 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$9.17 - $14.8 $116,330 - $187,752	12,686 Added 50.69%	37,714 $355,000
Q4 2020 Feb 09, 2021	BUY	$8.92 - $13.29 $101,331 - $150,974	11,360 Added 83.11%	25,028 $283,000
Q3 2020 Nov 10, 2020	SELL	$9.94 - $16.59 $5,655 - $9,439	-569 Reduced 4.0%	13,668 $146,000
Q2 2020 Aug 06, 2020	BUY	$12.07 - $19.34 $22,232 - $35,624	1,842 Added 14.86%	14,237 $216,000
Q1 2020 May 11, 2020	BUY	$12.5 - $22.04 $29,925 - $52,763	2,394 Added 23.94%	12,395 $193,000
Q4 2019 Feb 05, 2020	BUY	$11.42 - $22.19 $40,152 - $78,020	3,516 Added 54.22%	10,001 $187,000
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $16,582 - $25,065	1,125 Added 20.99%	6,485 $117,000
Q2 2019 Aug 08, 2019	BUY	$18.35 - $30.34 $98,356 - $162,622	5,360 New	5,360 $105,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account